Company Overview

ViewRay® Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdian® the world’s first MRI-guided radiation therapy system that can image and treat cancer patients simultaneously. MRIdian addresses key limitations of existing external-beam radiation therapy technologies because it integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered. Real-time MRI-imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment allowing the system to deliver radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian’s targeting accuracy combined with improved tumor visibility and accurate dose recording means clinicians can treat patients who may not previously have been considered radiation therapy candidates. ViewRay believes MRIdian may improve the safety and efficacy of radiation therapy, potentially leading to improved patient outcomes with reduced side-effects from off-target radiation delivery.

Financial News

Date Title and Summary Additional Formats
Toggle Summary Penn State Health Enters into Master Purchase Agreement with ViewRay for MRIdian® Systems
Immediate order of one system with ability to purchase an additional three systems CLEVELAND , Sept. 16, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Penn State Health has entered into a master agreement for the purchase of up to four MRIdian systems, placing an order for
Toggle Summary ViewRay Announces Collaboration with Stanford Health Care
Stanford Health Care to Acquire a ViewRay MRIdian System CLEVELAND , Sept. 12, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Stanford Health Care in Stanford, California , will acquire a MRIdian, the world's leading MR-guided radiation therapy system.
Toggle Summary Leading Radiation Oncology Meeting to Feature Unique Capabilities and Compelling Patient Outcomes with ViewRay's MRIdian
Clinicians from 17 Hospitals Worldwide to Present Clinical Experience with MRIdian MRI-Guided Radiation Therapy at ASTRO CLEVELAND , Sept. 10, 2019 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian® and MRIdian Linac MRI-guided radiation therapy systems will
Toggle Summary ViewRay to Host Investor Meeting at 2019 ASTRO Annual Meeting in Chicago
CLEVELAND , Aug. 27, 2019 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced that the Company will host a physician-led informational discussion for investors and analysts during the 2019 American Society of Radiation Oncology (ASTRO) Annual Meeting in Chicago .

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

Financial Events
More events are coming soon.

E-mail Alerts

Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now!
Click here for E-mail Alerts

Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449

In Need of Customer Support? Contact

  Language Select